Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem cell programs in cancer initiation, progression, and therapy resistance
Tianzhi Huang, Xiao Song, Dandan Xu, et al.
Theranostics (2020) Vol. 10, Iss. 19, pp. 8721-8743
Open Access | Times Cited: 336

Showing 1-25 of 336 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 146
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 117
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Anshika Goenka, Deanna Tiek, Xiao Song, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 484-484
Open Access | Times Cited: 109
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 95
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 51
Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer
Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa, et al.
Cytokine (2023) Vol. 171, pp. 156376-156376
Closed Access | Times Cited: 48
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun, Xiaorui Xing, Huanyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115586-115586
Open Access | Times Cited: 41
Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics
Prakash Gangadaran, Akanksha Onkar, Ramya Lakshmi Rajendran, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
Ritama Paul, Jay F. Dorsey, Yi Fan
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107985-107985
Open Access | Times Cited: 101
Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis
Li Sun, Chao‐Yuan Huang, Miaolin Zhu, et al.
Theranostics (2020) Vol. 10, Iss. 26, pp. 11950-11962
Open Access | Times Cited: 78
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Ying Liu, Xiang Ao, Yu Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 66
Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition
Ji Hyeon You, Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2021) Vol. 507, pp. 40-54
Closed Access | Times Cited: 62
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
Manni Wang, Wu Min
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 44
An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
Wenjing Wang, Jianmin Wang, Shuai Liu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Single‐cell RNA‐seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer
Yan Qian, Ertao Zhai, Sile Chen, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 8, pp. 1367-1381
Closed Access | Times Cited: 38
Dormant cancer cells: programmed quiescence, senescence, or both?
Kevin Truskowski, Sarah R. Amend, Kenneth J. Pienta
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 37-47
Open Access | Times Cited: 37
Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma
Kuo‐Shyang Jeng, Chiung‐Fang Chang, I-Shyang Sheen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1417-1417
Open Access | Times Cited: 31
The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 30
Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer
Zhengguang Li, Zhirong Yang, Wei Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Harnessing cancer stem cell-derived exosomes to improve cancer therapy
Jianqiang Yang, Yong Teng
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 26
The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1946-1973
Open Access | Times Cited: 23
MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis
Mohamed Ali Hussein, Kamyab Valinezhad, Eman Adel, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 234-234
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top